Supervised drug consumption sites offer opportunities for HCV testing and treatment
Do fatigue and quality of life improve after hepatitis C is cured?
Routine clinical use of DAAs highly effective and safe in people with HIV/HCV in Europe
Curing hepatitis C reduces deaths and liver disease
Direct-acting antivirals bring fewer HCV-related liver transplants, better survival after transplantation, in Europe
Eight weeks of treatment with Epclusa cured almost all people with HCV receiving opioid substitution therapy
New affordable hepatitis C combination shows 97% cure rate
8-week course of Zepatier cures acute HCV in people with HIV
